• locale

  United States

• market

  STOCKS

• industry

  Biotechnology

• website

  arrowheadpharma.com

• ipo date

  Dec 16, 1993

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombo...Show More

*Estimate based on analyst consensus